89.35
price down icon0.20%   -0.18
after-market After Hours: 89.40 0.05 +0.06%
loading
Dexcom Inc stock is traded at $89.35, with a volume of 2.47M. It is down -0.20% in the last 24 hours and up +3.50% over the past month. Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
See More
Previous Close:
$89.53
Open:
$89.64
24h Volume:
2.47M
Relative Volume:
0.73
Market Cap:
$35.03B
Revenue:
$4.15B
Net Income/Loss:
$535.20M
P/E Ratio:
66.68
EPS:
1.34
Net Cash Flow:
$575.20M
1W Performance:
+4.97%
1M Performance:
+3.50%
6M Performance:
+3.38%
1Y Performance:
+32.41%
1-Day Range:
Value
$88.97
$89.96
1-Week Range:
Value
$85.89
$89.96
52-Week Range:
Value
$57.52
$93.25

Dexcom Inc Stock (DXCM) Company Profile

Name
Name
Dexcom Inc
Name
Phone
(858) 200-0200
Name
Address
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Name
Employee
10,300
Name
Twitter
@dexcom
Name
Next Earnings Date
2024-10-24
Name
Latest SEC Filings
Name
DXCM's Discussions on Twitter

Compare DXCM with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
DXCM
Dexcom Inc
89.35 35.11B 4.15B 535.20M 575.20M 1.34
Medical Devices icon
ABT
Abbott Laboratories
128.01 219.83B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
106.47 156.58B 18.49B 2.51B 2.72B 1.68
Medical Devices icon
SYK
Stryker Corp
400.57 153.13B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
92.44 117.84B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
80.47 46.04B 5.69B 4.15B 623.10M 6.95

Dexcom Inc Stock (DXCM) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-16-25 Initiated Truist Buy
May-30-25 Initiated Goldman Buy
Apr-10-25 Initiated Mizuho Outperform
Feb-03-25 Upgrade Redburn Atlantic Neutral → Buy
Jan-16-25 Upgrade Robert W. Baird Neutral → Outperform
Jul-26-24 Downgrade JP Morgan Overweight → Neutral
Jul-26-24 Downgrade Robert W. Baird Outperform → Neutral
May-30-24 Initiated Redburn Atlantic Neutral
Mar-12-24 Initiated RBC Capital Mkts Outperform
May-30-23 Resumed Morgan Stanley Equal-Weight
Apr-17-23 Upgrade Raymond James Outperform → Strong Buy
Mar-29-23 Initiated UBS Buy
Jan-26-23 Initiated Wolfe Research Outperform
Oct-18-22 Initiated Barclays Equal Weight
Oct-12-22 Initiated Jefferies Buy
Jul-15-22 Initiated Bernstein Outperform
Mar-02-22 Resumed BofA Securities Buy
Feb-03-22 Upgrade BTIG Research Neutral → Buy
Jan-19-22 Upgrade Wells Fargo Equal Weight → Overweight
Jan-07-22 Upgrade Guggenheim Neutral → Buy
Oct-18-21 Downgrade Guggenheim Buy → Neutral
Jul-21-21 Resumed Cowen Outperform
May-28-21 Upgrade Wells Fargo Underweight → Equal Weight
May-25-21 Initiated Barclays Overweight
Apr-15-21 Initiated Atlantic Equities Overweight
Jan-06-21 Upgrade UBS Neutral → Buy
Oct-02-20 Downgrade Wells Fargo Equal Weight → Underweight
May-27-20 Reiterated Piper Sandler Overweight
May-14-20 Initiated Wells Fargo Equal Weight
Mar-05-20 Initiated Citigroup Buy
Nov-07-19 Reiterated Canaccord Genuity Buy
Nov-07-19 Upgrade Guggenheim Neutral → Buy
Oct-23-19 Initiated Stifel Buy
Nov-28-18 Initiated UBS Neutral
Oct-19-18 Upgrade Goldman Sell → Neutral
Sep-12-18 Upgrade Northland Capital Under Perform → Market Perform
Aug-02-18 Reiterated Canaccord Genuity Buy
Jul-02-18 Upgrade Raymond James Mkt Perform → Outperform
Jun-08-18 Upgrade JP Morgan Neutral → Overweight
May-11-18 Initiated BofA/Merrill Buy
May-03-18 Reiterated Canaccord Genuity Buy
Apr-04-18 Initiated Goldman Sell
Apr-04-18 Initiated Guggenheim Neutral
Mar-23-18 Upgrade Robert W. Baird Neutral → Outperform
Jan-04-18 Downgrade Northland Capital Market Perform → Under Perform
Sep-28-17 Reiterated Wedbush Outperform
View All

Dexcom Inc Stock (DXCM) Latest News

pulisher
01:24 AM

DexCom (DXCM) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo Finance

01:24 AM
pulisher
Jul 28, 2025

Earnings To Watch: DexCom (DXCM) Reports Q2 Results Tomorrow - Yahoo Finance

Jul 28, 2025
pulisher
Jul 28, 2025

DexCom Inc. Outperforms Peers on Volume MetricsFast Gaining Stock Screener Reports Released - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Why DexCom Inc. stock attracts strong analyst attentionReversal Alert Based on RSI Indicator Confirmed - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Dexcom launches AI-powered meal logging for CGM users - MassDevice

Jul 28, 2025
pulisher
Jul 28, 2025

Dexcom Rolls Out AI-Powered Meal Logging for Stelo CGM - Medical Product Outsourcing

Jul 28, 2025
pulisher
Jul 28, 2025

Dexcom's AI-Powered Smart Food Logging: A Game-Changer in Glucose Management and Metabolic Health Tech - AInvest

Jul 28, 2025
pulisher
Jul 28, 2025

Dexcom adds AI-powered food logging to Stelo glucose monitor By Investing.com - Investing.com India

Jul 28, 2025
pulisher
Jul 28, 2025

Dexcom Launches Revolutionary AI-Powered Meal Logging Feature Across Glucose Biosensing Portfolio | DXCM Stock News - GuruFocus

Jul 28, 2025
pulisher
Jul 28, 2025

Dexcom Launches Revolutionary AI-Powered Meal Logging Feature Across Glucose Biosensing Portfolio - DexCom Investor Relations

Jul 28, 2025
pulisher
Jul 28, 2025

Building a $33B Digital Health Juggernaut | Dexcom Chairman & CEO Kevin Sayer - iHeart

Jul 28, 2025
pulisher
Jul 28, 2025

What is the risk reward ratio of investing in DexCom Inc. stockFree Market Volatility Navigation Tips - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What catalysts could drive DexCom Inc. stock higher in 2025Achieve rapid financial growth with expert help - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How Dexcom leverages AI to tackle diabetes - Constellation Research

Jul 27, 2025
pulisher
Jul 26, 2025

Will DXCM Q2 Earnings Reflect U.S. Coverage Expansion & Stelo Impact? - MSN

Jul 26, 2025
pulisher
Jul 26, 2025

Mizuho Lifts PT on DexCom (DXCM) to $100 From $95, Keeps an Outperform Rating - MSN

Jul 26, 2025
pulisher
Jul 25, 2025

What drives DexCom Inc. stock pricePhenomenal wealth increase - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Will DexCom Inc. stock split in the near futureFree Market Volatility Navigation Tips - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Is DexCom, Inc.'s (NASDAQ:DXCM) ROE Of 24% Impressive? - Yahoo Finance

Jul 24, 2025
pulisher
Jul 23, 2025

DexCom Takes A Hit As Growth Meets New Headwinds - Finimize

Jul 23, 2025
pulisher
Jul 23, 2025

Is DexCom Inc. a good long term investmentFree Investment Case Studies - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about DexCom Inc. stockHigh-octane investment gains - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

DexCom Inc. Stock Analysis and ForecastFree Popular Stock Recommendations - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

We Think DexCom (NASDAQ:DXCM) Can Manage Its Debt With Ease - simplywall.st

Jul 22, 2025
pulisher
Jul 21, 2025

DexCom: Delivering Consistent Growth (NASDAQ:DXCM) - Seeking Alpha

Jul 21, 2025
pulisher
Jul 21, 2025

Still Too Pricey? Dexcom’s Double-Digit Growth May Not Be Enough (DXCM) - Seeking Alpha

Jul 21, 2025
pulisher
Jul 21, 2025

Are Medical Stocks Lagging DexCom (DXCM) This Year? - Yahoo Finance

Jul 21, 2025
pulisher
Jul 20, 2025

Why This Beaten-Down Medical Device Stock Could Be Your Best Investment for the Next 5 Years - AOL.com

Jul 20, 2025

Dexcom Inc Stock (DXCM) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Dexcom Inc Stock (DXCM) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
FOLETTA MARK G
Director
Jul 15 '25
Sale
85.17
2,750
234,217
53,871
Brown Michael Jon
EVP, Chief Legal Officer
Jul 15 '25
Sale
86.03
500
43,015
94,602
$77.72
price down icon 0.03%
medical_devices PHG
$28.02
price up icon 9.20%
medical_devices EW
$80.47
price up icon 2.52%
medical_devices STE
$228.37
price up icon 0.81%
$291.49
price down icon 0.27%
Cap:     |  Volume (24h):